{"id":"W4380085040","doi":"10.1002/hon.3163_91","title":"COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE AND SHOWS EARLY EFFICACY IN PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Tolerability; Lymphoma; Follicular lymphoma; Gastroenterology; Dosing; Oncology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002945985,0.0003215523,0.001076712,0.0002278027,0.0001374119,0.00002489366,0.0002006929,0.0004559632,0.0006576444],"category_scores_gemma":[0.0002559831,0.0002028431,0.00009072989,0.0004986053,0.0003361289,0.00007783445,0.0003196789,0.000539047,0.0003659412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001612778,"about_ca_system_score_gemma":0.0001980609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003266882,"about_ca_topic_score_gemma":0.00008217554,"domain_scores_codex":[0.9973073,0.0002076063,0.0005683012,0.0006756646,0.0004805012,0.0007606227],"domain_scores_gemma":[0.9974527,0.001651278,0.0001413184,0.0002921434,0.00009696538,0.0003656333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01276881,0.002274232,0.9581694,0.0001951802,0.0001076832,0.004860005,0.001414932,0.000001989368,0.002094826,0.0001423975,0.002304485,0.01566605],"study_design_scores_gemma":[0.01341273,0.007707255,0.9675258,0.0002149927,0.00004474695,0.0001135252,0.0002410718,0.0003330699,0.00119728,0.00009894173,0.008819847,0.0002907117],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923167,0.0001430375,0.000006778797,0.001636493,0.0001216047,0.000606609,0.00003804546,0.0001031156,0.005027612],"genre_scores_gemma":[0.9954564,0.0002076131,0.001132766,0.001007498,0.00006461937,0.00005810063,0.0001069427,0.00003469689,0.001931381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01537534,"threshold_uncertainty_score":0.8271703,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03924295893968783,"score_gpt":0.3232265847332438,"score_spread":0.283983625793556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}